Nationwide blood test trials hope to improve Alzheimer’s diagnosis rate
Thousands of people across the United Kingdom will have access to trials that could revolutionise the diagnosis of Alzheimer’s.
The blood tests could be ready for use in the NHS within five years as part of a drive to address the nation’s low diagnosis rate.
and will lead the trials to research the cheap tests for proteins in people with early stages
